Summary & Overview
HCPCS Level II J0620: Injection of Calcium Glycerophosphate and Calcium Lactate, per 10 ml
HCPCS Level II code J0620 denotes an injectable combination of calcium glycerophosphate and calcium lactate, billed per 10 ml. This code is used when parenteral calcium supplementation is administered in clinical settings such as hospital inpatient and outpatient departments, ambulatory clinics, and other sites that deliver injectable therapies. The code matters nationally because it standardizes reporting and reimbursement for a specific calcium formulation used in managing hypocalcemia and related conditions that require intravenous or intramuscular calcium replacement.
Key payers discussed include Aetna, Blue Cross Blue Shield, Cigna Health, UnitedHealthcare, and Medicare. Readers will find concise benchmarks and coverage context, an explanation of common billing practices tied to this injectable service, and clinical context for when this formulation is typically used. The summary outlines payer coverage patterns, coding considerations for service lines that administer parenteral medications, and implications for service delivery in settings where injectable calcium is provided. Data not available in the input is noted where applicable, and the publication focuses on national-level coding, coverage, and clinical use rather than state-specific policies.
Billing Code Overview
HCPCS Level II code J0620 represents an injection of calcium glycerophosphate and calcium lactate, billed per 10 ml. This code covers the provision of a combined calcium preparation delivered by injection for clinical indications requiring calcium supplementation or replacement.
-
Service type: Injectable medication administration
-
Typical site of service: Hospital inpatient, hospital outpatient, clinic, or other settings where parenteral medications are administered
Clinical & Coding Specifications
Clinical Context
A typical patient is an adult admitted to an inpatient medical or surgical unit with documented or suspected hypocalcemia or a need for rapid parenteral calcium repletion when oral therapy is not feasible. Common scenarios include postoperative patients with poor enteral intake, critically ill patients with sepsis-associated hypocalcemia, patients with malabsorption or short-gut syndromes, or patients receiving total parenteral nutrition who develop symptomatic low serum calcium. The medication described by J0620 (injection, calcium glycerophosphate and calcium lactate, per 10 ml) is administered intravenously by a registered nurse or advanced practice clinician under physician or hospital protocol.
Typical workflow: the ordering provider documents the indication and dose in the medical record and selects the J0620 product. Pharmacy verifies compatibility and prepares the 10 ml vial or syringe. At bedside, the nurse confirms patient identity, checks baseline serum calcium (and other electrolytes as indicated), obtains IV access if not already present, performs allergy and infusion checks, and administers the injection per facility protocol (bolus or slow IV push/infusion depending on institutional guidelines and patient status). Post-administration monitoring includes serial calcium levels, cardiac monitoring for patients with significant electrolyte disturbance, and documentation of volume, lot number, and any adverse reactions in the medication administration record.
Coding Specifications
| Modifier | Description | When to Use |
|---|